These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 6189927)
1. The antitumor effect of interferon against murine osteogenic sarcoma. Satomi H Nihon Seikeigeka Gakkai Zasshi; 1983 Feb; 57(2):199-213. PubMed ID: 6189927 [TBL] [Abstract][Full Text] [Related]
2. Effect of interferon administration on pulmonary osteogenic sarcomas in an experimental murine model. Glasgow LA; Kern ER J Natl Cancer Inst; 1981 Jul; 67(1):207-12. PubMed ID: 6166780 [TBL] [Abstract][Full Text] [Related]
3. Antitumor activity of interferon against murine osteogenic sarcoma in vitro and in vivo. Glasgow LA; Crane JL; Kern ER; Youngner JS Cancer Treat Rep; 1978 Nov; 62(11):1881-8. PubMed ID: 282006 [TBL] [Abstract][Full Text] [Related]
4. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: successful immunotherapy of established pulmonary metastases from weakly immunogenic and nonimmunogenic murine tumors of three district histological types. Papa MZ; Mulé JJ; Rosenberg SA Cancer Res; 1986 Oct; 46(10):4973-8. PubMed ID: 3489517 [TBL] [Abstract][Full Text] [Related]
5. A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung. Benjamin R; Helman L; Meyers P; Reaman G Hum Gene Ther; 2001 Aug; 12(12):1591-3. PubMed ID: 11529247 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of murine osteogenic sarcomas by treatment with type I or type II interferon. Crane JL; Glasgow LA; Kern ER; Youngner JS J Natl Cancer Inst; 1978 Sep; 61(3):871-4. PubMed ID: 278865 [TBL] [Abstract][Full Text] [Related]
7. Anti-CD3 + IL-2-stimulated murine killer cells. In vitro generation and in vivo antitumor activity. Anderson PM; Blazar BR; Bach FH; Ochoa AC J Immunol; 1989 Feb; 142(4):1383-94. PubMed ID: 2521662 [TBL] [Abstract][Full Text] [Related]
8. Role of natural killer and T-cells in interferon induced inhibition of spontaneous metastases of the B16F10L murine melanoma. Markovic SN; Murasko DM Cancer Res; 1991 Feb; 51(4):1124-8. PubMed ID: 1705166 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4. Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566 [TBL] [Abstract][Full Text] [Related]
10. LacZ transgene expression in the subcutaneous Dunn/LM8 osteosarcoma mouse model allows for the identification of micrometastasis. Arlt MJ; Banke IJ; Walters DK; Puskas GJ; Steinmann P; Muff R; Born W; Fuchs B J Orthop Res; 2011 Jun; 29(6):938-46. PubMed ID: 21284029 [TBL] [Abstract][Full Text] [Related]
11. [The effect of CdCl2 and ZnCl2 on Dunn osteosarcoma]. Noda K Nihon Seikeigeka Gakkai Zasshi; 1990 Jan; 64(1):70-5. PubMed ID: 2319195 [TBL] [Abstract][Full Text] [Related]
12. Attenuated Salmonella typhimurium with interleukin 2 gene prevents the establishment of pulmonary metastases in a model of osteosarcoma. Sorenson BS; Banton KL; Frykman NL; Leonard AS; Saltzman DA J Pediatr Surg; 2008 Jun; 43(6):1153-8. PubMed ID: 18558199 [TBL] [Abstract][Full Text] [Related]
13. Studies on the antitumor activities of pyrimidinone-interferon inducers. I. Effect against artificial and spontaneous lung metastases of murine tumors. Milas L; Hersh EM; Stringfellow DA; Hunter N J Natl Cancer Inst; 1982 Jan; 68(1):139-45. PubMed ID: 6172625 [TBL] [Abstract][Full Text] [Related]
14. Oral administration of 1 alpha hydroxyvitamin D3 inhibits tumor growth and metastasis of a murine osteosarcoma model. Hara K; Kusuzaki K; Takeshita H; Kuzuhara A; Tsuji Y; Ashihara T; Hirasawa Y Anticancer Res; 2001; 21(1A):321-4. PubMed ID: 11299756 [TBL] [Abstract][Full Text] [Related]
15. Intranasal therapy with an adenoviral vector containing the murine interleukin-12 gene eradicates osteosarcoma lung metastases. Worth LL; Jia SF; Zhou Z; Chen L; Kleinerman ES Clin Cancer Res; 2000 Sep; 6(9):3713-8. PubMed ID: 10999765 [TBL] [Abstract][Full Text] [Related]
16. Effect of immunotherapy with allogeneic lymphokine-activated killer cells and recombinant interleukin 2 on established pulmonary and hepatic metastases in mice. Shiloni E; Lafreniere R; Mulé JJ; Schwarz SL; Rosenberg SA Cancer Res; 1986 Nov; 46(11):5633-40. PubMed ID: 3489526 [TBL] [Abstract][Full Text] [Related]
19. Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy. Mulé JJ; Ettinghausen SE; Spiess PJ; Shu S; Rosenberg SA Cancer Res; 1986 Feb; 46(2):676-83. PubMed ID: 3484431 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of primary and metastatic tumor growth in mice by cancer-associated galactosyltransferase acceptor. Podolsky DK; Carter EA; Isselbacher KJ Cancer Res; 1983 Sep; 43(9):4026-30. PubMed ID: 6409394 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]